Seminars in Perinatology
Volume 31, Issue 3 , Pages 159-166 , June 2007

Postpartum Hemorrhage: A Recurring Pregnancy Complication

  • Michelle A. Kominiarek, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN.
    • Corresponding Author InformationAddress reprint requests to Michelle A. Kominiarek, MD, 550 North University Boulevard, Room 2440, Department of Obstetrics and Gynecology, Indianapolis, IN 46202.
    • ,
  • Sarah J. Kilpatrick, MD, PhD

      Affiliations

    • Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL.

References 

  1. AbouZahr C. Global burden of maternal death and disability. Br Med Bull. 2003;67:1–11
  2. Combs CA, Murphy EL, Laros RK. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol. 1991;77:69–76
  3. Doran JR, O’Brien SA, Randall JH. Repeated postpartum hemorrhage. Obstet Gynecol. 1955;5:186–192
  4. Jansen AJG, van Rhenen DJ, Steegers EAP, et al. Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv. 2005;60:663–671
  5. Hoveyda F, MacKenzie IZ. Secondary postpartum haemorrhage: incidence, morbidity and current management. Br J Obstet Gynaecol. 2002;108:927–930
  6. King PA, Duthie SJ, Dong ZG, et al. Secondary postpartum hemorrhage. Aust NZ J Obstet Gynaecol. 1989;29:394–398
  7. Sheiner E, Sarid L, Levy A, et al. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neo Med. 2005;18:149–154
  8. Stones RW, Paterson CM, Saunders NJ. Risk factors for major obstetric hemorrhage. Eur J Obstet Gynecol Reprod Biol. 1993;48:15–18
  9. Brinsden PR, Clark AD. Postpartum haemorrhage after induced and spontaneous labour. Br Med J. 1978;2:855–856
  10. Tsu VD. Postpartum haemorrhage in Zimbabwe: a risk factor analysis. Br J Obstet Gynaecol. 1993;100:327–333
  11. Hall MH, Halliwell R, Carr-Hill R. Concomitant and repeated happenings of complications of the third stage of labour. Br J Obstet Gynaecol. 1985;92:732–738
  12. Dewhurst CJ, Dutton WAW. Recurrent abnormalities of the third stage of labour. Lancet. 1957;273:764–767
  13. Magann EF, Evans S, Hutchinson M, et al. Postpartum hemorrhage after vaginal birth: an analysis of risk factors. Southern Med J. 2005;98:419–422
  14. Mongelli M. Secondary post-partum haemorrhage: a recurrent condition?. Clin Exp Obstet Gynecol. 1992;19:97
  15. Nizard J, Barrinque L, Frydman R, et al. Fertility and pregnancy outcomes following hypogastric artery ligation for severe post-partum haemorrhage. Hum Reprod. 2003;18:844–848
  16. Descargues G, Tinlot FM, Douvrin F, et al. Menses, fertility and pregnancy after arterial embolization for the control of postpartum haemorrhage. Hum Reprod. 2004;19:339–343
  17. Stancato-Pasik A, Mitty H, Richard HM, et al. Obstetric embolotherapy: effect on menses and pregnancy. Radiology. 1997;204:791–793
  18. Salomon LJ, De Tayrac R, Castaigne-Meary V, et al. Fertility and pregnancy outcome following pelvic arterial embolization for severe post-partum haemorrhage (A cohort study). Hum Reprod. 2003;18:849–852
  19. B-Lynch C, Coker A, Lawal AH, et al. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? (Five cases reported). Br J Obstet Gynaecol. 1997;104:372–375
  20. Api M, Api O, Yayla M. Fertility after B-lynch suture and hypogastric artery ligation. Fertil Steril. 2005;84:509
  21. Goldberg J, Pereira L, Berghella V. Pregnancy after uterine artery embolization. Obstet Gynecol. 2002;100:869–872
  22. Qidwai GI, Caughey AB, Jacoby AF. Obstetric outcomes in women with sonographically identified uterine leiomyomata. Obstet Gynecol. 2006;107:376–382
  23. Hasan F, Arumugam K, Sivanesaratnam V. Uterine leiomyomata in pregnancy. Int J Gynecol Obstet. 1990;34:45–48
  24. Winer-Muram HT, Muram D, Gilleison MS. Uterine myomas in pregnancy. J Can Assoc Radiol. 1984;35:168–170
  25. Muram D, Gillieson MS, Walters JH, et al. Myomas of the uterus in pregnancy: ultrasonographic follow-up. Am J Obstet Gynecol. 1980;138:16–19
  26. Roberts WE, Fulp KS, Morrison JC, et al. The impact of leiomyomas on pregnancy. Aust NZ J Obstet Gynaecol. 1999;39:43–47
  27. Vergani P, Ghidini A, Stobelt N, et al. Do uterine leiomyomas influence pregnancy outcome. Am J Perinatol. 1994;11:356–358
  28. Lev-Toaff AS, Coleman BG, Arger PH, et al. Leiomyomas in pregnancy: a sonographic study. Radiology. 1987;164:375–380
  29. Goldberg J, Pereira L, Berghella V, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol. 2004;191:18–21
  30. Carpenter TT, Walker WJ. Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. Br J Obstet Gynaecol. 2005;112:321–325
  31. Seracchioli R, Manuzzi L, Vianello F, et al. Obstetric and delivery outcome of pregnancies achieved after laparoscopic myomectomy. Fertil Steril. 2006;86:159–165
  32. Walker WJ, McDowell SJ. Pregnancy after uterine artery emoblization for leiomyomata: a series of 56 completed pregnancies. Am J Obstet Gynecol. 2006;195:1266–1271
  33. Pron G, Mocarski E, Bennett J, et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol. 2005;105:67–76
  34. Tandberg A, Albrechtsen S, Iversen OE. Manual removal of the placenta: incidence and clinical significance. Acta Obstet Gynecol Scand. 1999;78:33–36
  35. VanBeekhuizen ME, Vierhout ME. Risk of recurrence of retained placenta. Med Tijdschr Geneeskd. 1994;138:2149–2152
  36. Titiz H, Wallace A, Voaklander DC. Manual removal of the placenta: a case control study. Aust NZ J Obstet Gynaecol. 2001;41:41–44
  37. Platt LD, Druzin ML. Acute puerperal inversion of the uterus. Am J Obstet Gynecol. 1981;141:187–190
  38. Watson P, Besch N, Bowes WA. Management of acute and subacute puerperal inversion of the uterus. Obstet Gynecol. 1980;55:12–16
  39. Miller NF. Pregnancy following inversion of the uterus. Am J Obstet Gynecol. 1927;13:307–322
  40. Baskett TF. Acute uterine inversion: a review of 40 cases. J Obstet Gynaecol Can. 2002;24:953–956
  41. Ramsahoye BH, Davies SV, Dasani H, et al. Obstetric management in von Willebrand’s disease: a report of 24 pregnancies and a review of the literature. Haemophilia. 1995;1:140–144
  42. Kadir RA, Lee CA, Sabin CA, et al. Pregnancy in women with von Willebrand’s disease or factor XI deficiency. Br J Obstet Gynaecol. 1998;105:314–321
  43. Greer IA, Lowe GDO, Walker JJ, et al. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynecol. 1991;98:909–918
  44. Kirtava A, Crudder S, Dilley A, et al. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia. 2004;10:158–161
  45. Kujovich JL. Von Willebrand disease and pregnancy. J Thromb Haemost. 2005;3:246–253
  46. Kouides PA, Phatak PD, Burkart P, et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia. 2000;6:643–648
  47. Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia. 1999;5:313–317
  48. Hundegger R, Husslein P, Berghammer P, et al. Postpartum bleeding and von Willebrand’s disease. Arch Gynecol Obstet. 2002;266:160–162
  49. American College of Obstetricians and Gynecologists Committee Opinion #263. Von Willebrand’s disease in gynecologic practice, 2001
  50. American College of Obstetricians and Gynecologists Committee Opinion #329. Menstruation in girls and adolescents. Using the menstrual cycle as a vital sign, 2006
  51. Girolami A, Randi ML, Ruzzon E, et al. Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors. Acta Haematol. 2006;115:58–63
  52. Kadir RA, O’Connell NM, Economides DL, et al. Screening for factor XI deficiency amongst pregnant women of Ashkenazi Jewish origin. Haemophilia. 2006;12:625–628
  53. Shpilherg O, Peretz H, Zivelin R, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type 11) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood. 1995;85:429–432
  54. Bolton-Maggs PHB, Wan-Yin BY, McCraw AH, et al. Inheritance and bleeding in factor XI deficiency. Br J Haemotol. 1988;69:521–528
  55. Kadir RA, Economides DL, Braithwaite J, et al. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol. 1997;104:803–810
  56. Maslovitz S, Many A, Landsberg JA, et al. The safety of low molecular weight heparin therapy during labor. J Matern Fetal Neonat Med. 2005;17:39–43
  57. Rowan JA, McLintock C, Taylor RS, et al. Prophylactic and therapeutic enoxaparin during pregnancy: Indications, outcomes, and monitoring. Aust NZ J Obstet Gynecol. 2003;43:123–128
  58. Borna S, Borna H, Zhazardoost S. Maternal and neonatal outcomes in pregnant women with immune thrombocytopenic purpura. Arch Iranian Med. 2006;9:115–118
  59. Hwa HL, Wang TR, Huang SC, et al. Maternal and fetal outcome of pregnant women with idiopathic thrombocytopenic purpura: retrospective analysis of 25 cases. J Formos Med Assoc. 1993;92:957–961
  60. Lind J, Wallenburg HCS. Pregnancy and the Ehlers-Danlos syndrome: a retrospective study in a Dutch population. Acta Obstet Gynecol Scand. 2002;81:293–300
  61. Volkov N, Nisenblat V, Ohel G, et al. Ehlers-Danlos syndrome: insights on obstetric aspects. Obstet Gynecol Surv. 2007;62:51–57
  62. Rosnes JS, Sharkey MF, Veille JC, et al. Gaucher’s disease in pregnancy. Obstet Gynecol Surv. 1996;51:549–558
  63. Young BK, Gorstein F. Maternal osteogenesis imperfecta. Obstet Gynecol. 1968;31:461–470
  64. Rahman J, al-Suleiman SA, Rahman MS, et al. Obstetric and gynecologic complications in women with Marfan syndrome. J Reprod Med. 2004;48:723–728
  65. Meijboom L, Drenthen W, Pieper PG, et al. Obstetric complications in Marfan syndrome. Int J Card. 2006;110:53–59
  66. Jackson KW, Allbert JR, Schemmer GK, et al. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol. 2001;185:873–877
  67. McCurdy C, Magann E, McCurdy C, et al. The effect of placental management at cesarean delivery on operative blood loss. Am J Obstet Gynecol. 1992;167:1363
  68. American College of Obstetricians and Gynecologists Practice Bulletin #76. Postpartum hemorrhage, 2006
  69. VanSelm M, Kanhai HHH, Keirse M. Preventing the recurrence of atonic postpartum hemorrhage: a double-blind trial. Acta Obstet Gynecol Scand. 1995;74:270–274
  70. Newton M, Mosey LM, Egli GE, et al. Blood loss during and immediately after delivery. Obstet Gynecol. 1961;17:9–18
  71. McVay PA, Hoag RW, Hoag MS, et al. Safety and use of autologous blood donation during the third trimester of pregnancy. Am J Obstet Gynecol. 1989;160:1479–1488
  72. Herbert WN, Owen HG, Collins ML. Autologous blood storage in obstetrics. Obstet Gynecol. 1988;72:166–170
  73. Andres AL, Piacquadio KM, Resnik R, et al. A reappraisal of the need for autologous blood donation in the obstetric patient. Am J Obstet Gynecol. 1990;163:1551–1552
  74. Combs CA, Murphy EL, Laros RK. Cost-benefit analysis of autologous blood donation in obstetrics. Obstet Gynecol. 1992;80:621–625

PII: S0146-0005(07)00032-8

doi: 10.1053/j.semperi.2007.03.001

Seminars in Perinatology
Volume 31, Issue 3 , Pages 159-166 , June 2007

Article Tools